New Results
Preliminary report on SARS-CoV-2 Spike mutation T478K
View ORCID ProfileSimone Di Giacomo, View ORCID ProfileDaniele Mercatelli, View ORCID ProfileAmir Rakhimov, View ORCID ProfileFederico M. Giorgi
doi: https://doi.org/10.1101/2021.03.28.437369
Simone Di Giacomo
1Department of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 40138, Bologna, Italy
Daniele Mercatelli
1Department of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 40138, Bologna, Italy
Amir Rakhimov
1Department of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 40138, Bologna, Italy
Federico M. Giorgi
1Department of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 40138, Bologna, Italy
Posted May 04, 2021.
Preliminary report on SARS-CoV-2 Spike mutation T478K
Simone Di Giacomo, Daniele Mercatelli, Amir Rakhimov, Federico M. Giorgi
bioRxiv 2021.03.28.437369; doi: https://doi.org/10.1101/2021.03.28.437369
Subject Area
Subject Areas
- Biochemistry (8828)
- Bioengineering (6532)
- Bioinformatics (23484)
- Biophysics (11805)
- Cancer Biology (9223)
- Cell Biology (13336)
- Clinical Trials (138)
- Developmental Biology (7442)
- Ecology (11425)
- Epidemiology (2066)
- Evolutionary Biology (15173)
- Genetics (10453)
- Genomics (14056)
- Immunology (9187)
- Microbiology (22199)
- Molecular Biology (8823)
- Neuroscience (47626)
- Paleontology (351)
- Pathology (1431)
- Pharmacology and Toxicology (2493)
- Physiology (3736)
- Plant Biology (8090)
- Synthetic Biology (2224)
- Systems Biology (6042)
- Zoology (1254)